Fabchem China Past Earnings Performance
Past criteria checks 0/6
Fabchem China has been growing earnings at an average annual rate of 3.5%, while the Chemicals industry saw earnings growing at 0.2% annually. Revenues have been declining at an average rate of 24.7% per year.
Key information
3.5%
Earnings growth rate
3.5%
EPS growth rate
| Chemicals Industry Growth | 0.9% |
| Revenue growth rate | -24.7% |
| Return on equity | -218.8% |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2021 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Fabchem China makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 21 | 0 | -1 | 1 | 0 |
| 30 Sep 21 | 0 | -1 | 1 | 0 |
| 30 Jun 21 | 0 | -1 | 1 | 0 |
| 31 Mar 21 | 27 | -3 | 11 | 0 |
| 31 Dec 20 | 27 | -5 | 11 | 0 |
| 30 Sep 20 | 27 | -7 | 11 | 0 |
| 30 Jun 20 | 24 | -7 | 10 | 0 |
| 31 Mar 20 | 0 | -2 | 2 | 0 |
| 31 Dec 19 | 22 | -30 | 10 | 0 |
| 30 Sep 19 | 24 | -29 | 10 | 0 |
| 30 Jun 19 | 27 | -29 | 10 | 0 |
| 31 Mar 19 | 31 | -30 | 11 | 0 |
| 31 Dec 18 | 36 | -5 | 10 | 0 |
| 30 Sep 18 | 36 | -5 | 10 | 0 |
| 30 Jun 18 | 39 | -5 | 10 | 0 |
| 31 Mar 18 | 40 | -4 | 11 | 0 |
| 31 Dec 17 | 37 | -2 | 11 | 0 |
| 30 Sep 17 | 36 | -3 | 11 | 0 |
| 30 Jun 17 | 33 | -4 | 10 | 0 |
| 31 Mar 17 | 30 | -5 | 10 | 0 |
| 31 Dec 16 | 25 | -10 | 10 | 0 |
| 30 Sep 16 | 25 | -10 | 10 | 0 |
| 30 Jun 16 | 29 | -8 | 11 | 0 |
| 31 Mar 16 | 41 | -5 | 12 | 0 |
| 31 Dec 15 | 49 | -3 | 13 | 0 |
| 30 Sep 15 | 64 | 1 | 14 | 0 |
Quality Earnings: BFT is currently unprofitable.
Growing Profit Margin: BFT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BFT is unprofitable, but has reduced losses over the past 5 years at a rate of 3.5% per year.
Accelerating Growth: Unable to compare BFT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BFT is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-21.2%).
Return on Equity
High ROE: BFT has a negative Return on Equity (-218.85%), as it is currently unprofitable.